PHAT | Phathom PharmaceuticalsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$5.74
-$0.17 (-2.96%)

Phathom Pharmaceuticals (PHAT) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2021.

The 50 SMA has sat below the 200 on the daily since Mar 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour. On the weekly a death cross is projected within 10 bars.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $5.74 vs 50 $7.52 / 200 $10.35
Projection
No cross projected
Test
No active test
Last cross
Death cross 26 Mar 2026 ยท projected 29 bars out ยท tested 1 bar

Weekly as of 30 Oct 16:00 ET

Price
below both $5.74 vs 50 $11.25 / 200 $10.45
Projection
Death cross projected in 5 bars
Test
No active test
Last cross
Golden cross week of 16 Feb 2026 ยท projected 26 bars out ยท tested 7 bars

4-hour as of 3 Nov 13:30 ET

Price
below both $5.57 vs 50 $6.74 / 200 $8.94
Projection
No cross projected
Test
No active test
Last cross
Death cross 12 Feb 2026 ยท projected 29 bars out

Cross history

20
crosses on record since 2021
10 golden10 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
26 Mar 2026Death steepdaily29 bars out1 bar cross test
week of 16 Feb 2026Golden moderateweekly26 bars out7 bar cross test
12 Feb 2026Death4-hour29 bars outNot tested
30 Jul 2025Golden steepdaily30 bars out2 bar cross test
13 Jun 2025Golden4-hour11 bars outโ€”

About PHAT

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$9.7M
4-hour coverageYes, since Oct 2025
History on recordSince 2021
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.